Earlier this week, the US Justice Department announced that pharmaceutical giant Johnson & Johnson agreed to pay more than $2 billion in fines and penalties for illegally marketing the drug Risperdal to doctors and patients.
New York Governor Andrew Cuomo’s anti-corruption commission held another hearing Monday evening focusing on reforming the state’s campaign finance system. A reform group is out with a report that they say raises questions about five million dollars spent on lobbying and donations by the pharmaceutical industry.
The Supreme Court’s decision that no company can patent genes but can patent its tests for genetic information is the tip of a large iceberg. We have gotten used to believing that the patent process is the only way that new drugs and treatments are developed, and that private industry is the only source of that work. Nothing could be further from the truth but the attack on government activity may make it true.